Physician

Alice Scott Mims, M.D.

According to 2025 Medicare claims, Alice Mims, M.D. (NPI: 1699962084) practices unknown physician specialty in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU INTERNAL MEDICINE, LLC (NPI: 1740231448; TIN: 311369596) and primary practice location at 43210-1240. Mims is affiliated with the Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Mims' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 119 traditional Medicare patients, billed 364 HCPCS/CPT codes, and received $27,579 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 846 prescription claims across 97 beneficiaries totaling $6,472,266 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2022 DME data shows 24 claims. Open Payments data shows 22 records totaling $110,223. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $54,909 to $27,579. In contrast, Part D prescription costs have risen steadily, from $675,631 to $6,472,266. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	228	940	$54,909
2016	104	383	$27,119
2017	137	776	$54,357
2018	155	635	$41,973
2019	101	358	$23,231
2020	134	492	$33,315
2021	113	390	$31,087
2022	128	380	$28,396
2023	103	271	$20,994
2024	119	364	$27,579

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	87	548	$675,631
2016	33	108	$370,867
2017	40	171	$385,851
2018	50	213	$1,122,658
2019	38	215	$2,121,355
2020	39	160	$1,695,269
2021	53	291	$2,982,298
2022	85	588	$3,495,993
2023	94	709	$4,835,201
2024	97	846	$6,472,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$119
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$1,688
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	11	11	$137
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	24	43	$109
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	25	88	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	58	114	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	43	59	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	78	2,340	$1,153,054
Rezurock	Belumosudil Mesylate	34	1,020	$852,831
Scemblix	Asciminib Hydrochloride	43	1,290	$837,418
Promacta	Eltrombopag Olamine	17	510	$650,819
Idhifa	Enasidenib Mesylate	17	510	$581,314

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$3,327	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$106,896	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alice Scott Mims, M.D.?

Tedicare shows public-source Medicare data for Alice Scott Mims, M.D. (NPI 1699962084), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alice Scott Mims, M.D. have ACO affiliation data?

Alice Scott Mims, M.D. is shown with ACO affiliation data for Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Alice Scott Mims, M.D.?

Alice Scott Mims, M.D. is linked to OSU INTERNAL MEDICINE, LLC (billing NPI 1740231448) in the available physician profile data.

Does Alice Scott Mims, M.D. have Open Payments data?

Alice Scott Mims, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.